| Dr Donald George Salazar, PHARMD | |
|
3520 Tyler St, Riverside, CA 92503-4175 | |
| (951) 351-1083 | |
| (951) 351-1083 |
| Full Name | Dr Donald George Salazar |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 3520 Tyler St, Riverside, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053606608 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 53630 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Donald George Salazar, PHARMD 3520 Tyler St, Riverside, CA 92503-4175 Ph: (951) 351-1083 | Dr Donald George Salazar, PHARMD 3520 Tyler St, Riverside, CA 92503-4175 Ph: (951) 351-1083 |
News Archive
Providers of home medical equipment and services across California are proposing a fiscally responsible alternative to the mislabeled "competitive" bidding scheme currently under way in Medicare that will actually discourage competition, reduce access to care for many of California's 4.6 million Medicare beneficiaries, and put thousands of California homecare providers out of business.
Cavitation during upper cervical high-velocity, low amplitude thrust manipulation is significantly more likely to occur bilaterally than unilaterally, say investigators.
On Wednesday, the British Medical Journal (BMJ) and the Lancet simultaneously published an editorial (available here and here) and an accompanying letter (here and here) from 18 doctor association leaders to highlight the need for action at a December U.N. conference on climate change in Copenhagen, Reuters reports (Doyle, 9/16).
NexMed, Inc., a specialty CRO and a developer of products based on the NexACT® technology, today announced that pre-clinical results from its research and development group at Bio-Quant successfully demonstrated the ability of the NexACT technology to deliver an oral formulation of Taxol® (paclitaxel) and to enhance the drug's bioavailability by approximately ten-fold through this oral administration. Taxol, a first line chemotherapy drug used to treat breast, lung and ovarian cancers, is currently administered through an intravenous infusion that can take up to 24 hours to complete.
The group turns to a federal district court as it seeks to have a new Kansas budget provision overturned.
› Verified 4 days ago
Vi T Dang, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3849 Chicago Ave, Riverside, CA 92507 Phone: 951-684-7416 Fax: 951-684-4659 | |
Dr. Ian Rojas, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9211 Shamouti Dr, Riverside, CA 92508 Phone: 951-552-5614 | |
Vy Nguyen, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10800 Magnolia Ave, Riverside, CA 92505 Phone: 951-353-5017 Fax: 951-353-4208 | |
Hayley Noelle Cliatt, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9990 County Farm Rd Ste 2, Riverside, CA 92503 Phone: 951-358-4700 | |
Faria Seanpanah, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8938 Trautwein Rd, Riverside, CA 92508 Phone: 951-656-3394 | |
Connie Chu Lee, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11080 Magnolia Ave, Riverside, CA 92505 Phone: 951-602-4137 | |
Dr. Kathleen A Dinh, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4790 La Sierra Ave, Riverside, CA 92505 Phone: 951-688-4196 Fax: 951-688-7822 |